Sign In
Buy LFMD
$4.56
-0.130 (-2.77%)
At Close: Jun 03, 2026
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
07:42pm, Wednesday, 08'th May 2024
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer C
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)
08:45am, Wednesday, 08'th May 2024
NEW YORK , May 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The investigation seeks to dete
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
08:26am, Friday, 03'rd May 2024
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD and Withings Health Solutions part
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
08:00am, Monday, 29'th Apr 2024
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician
LifeMD to Report First Quarter 2024 Financial Results on May 8
08:00am, Wednesday, 24'th Apr 2024
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
08:00am, Tuesday, 26'th Mar 2024
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
08:00am, Monday, 25'th Mar 2024
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needha
LifeMD Shares Come Back to Life on GLP-1 Business Growth
06:05am, Tuesday, 19'th Mar 2024
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and Shapiro
3 Stocks That Could Benefit from the Rise of Telemedicine
12:44pm, Thursday, 14'th Mar 2024
With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That's according to Emergen Research.
LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
10:07am, Wednesday, 13'th Mar 2024
LifeMD reported impressive revenue growth, with a 60% increase to $44.9 million, driven by a 90% increase in telehealth revenues. Weight management subscribers more than doubled sequentially, resultin
Can WeightWatchers Regain Its Mojo after Oprah Steps Down?
07:04am, Wednesday, 13'th Mar 2024
WW International Inc. NASDAQ: WW (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). The company made a praiseworthy strategic pivot in 2023, acquiring Seq
LifeMD, Inc. (LFMD) Q4 2023 Earnings Call Transcript
07:21pm, Monday, 11'th Mar 2024
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2023 Earnings Conference Call March 11, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - CFO Conference Call Participants David L
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
06:31pm, Monday, 11'th Mar 2024
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.02 per share a year ago.
LifeMD Reports Fourth Quarter 2023 Results
04:05pm, Monday, 11'th Mar 2024
Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year
